The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Peter Bader

University Children's Hospital

Department of Pediatric Hematology and Oncology

Hoppe-Seyler-Strasse 1

D-72070 Tübingen

Germany

[email]@med.uni-tuebingen.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • University Children's Hospital, Department of Pediatric Hematology and Oncology, Hoppe-Seyler-Strasse 1, D-72070 Tübingen, Germany. 2005
  • University Children's Hospital, Tübingen, Germany. 2000 - 2004
  • Department of Paediatric Hematology and Oncology, University Children's Hospital, Tuebingen, Germany. 2004

References

  1. How and when should we monitor chimerism after allogeneic stem cell transplantation?. Bader, P., Niethammer, D., Willasch, A., Kreyenberg, H., Klingebiel, T. Bone Marrow Transplant. (2005) [Pubmed]
  2. Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Kremens, B., Dilloo, D., Sykora, K.W., Niemeyer, C., Reinhardt, D., Vormoor, J., Gruhn, B., Lang, P., Greil, J., Handgretinger, R., Niethammer, D., Klingebiel, T., Beck, J.F. Bone Marrow Transplant. (2004) [Pubmed]
  3. Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?. Bader, P., Kreyenberg, H., Hoelle, W., Dueckers, G., Handgretinger, R., Lang, P., Kremens, B., Dilloo, D., Sykora, K.W., Schrappe, M., Niemeyer, C., Von Stackelberg, A., Gruhn, B., Henze, G., Greil, J., Niethammer, D., Dietz, K., Beck, J.F., Klingebiel, T. J. Clin. Oncol. (2004) [Pubmed]
  4. WT1 gene expression: useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?. Bader, P., Niemeyer, C., Weber, G., Coliva, T., Rossi, V., Kreyenberg, H., Gerecke, A., Biondi, A. Eur. J. Haematol. (2004) [Pubmed]
  5. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Bader, P., Stoll, K., Huber, S., Geiselhart, A., Handgretinger, R., Niemeyer, C., Einsele, H., Schlegel, P.G., Niethammer, D., Beck, J., Klingebiel, T. Br. J. Haematol. (2000) [Pubmed]
 
WikiGenes - Universities